Tefron Ltd. (TLV:TFRLF)

Verve Therapeutics Ratios and Metrics

Market cap in millions ILS. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	273	344	164	110	287	67
Market Cap Growth	42.51%	110.17%	48.94%	-61.76%	326.75%	99.12%
Enterprise Value	291	384	241	315	393	171
Last Close Price	20.14	31.68	18.99	8.46	22.67	5.72
PE Ratio	5.80	6.25	4.16	4.20	6.44	4.60
PS Ratio	0.26	0.32	0.19	0.14	0.35	0.12
PB Ratio	0.95	1.23	0.72	0.60	2.10	0.77
P/TBV Ratio	1.06	1.38	0.78	0.67	2.24	0.84
P/FCF Ratio	4.47	4.19	1.08	-	-	13.79
P/OCF Ratio	2.72	3.06	0.98	-	-	5.74
EV/Sales Ratio	0.32	0.36	0.28	0.40	0.48	0.30
EV/EBITDA Ratio	3.29	3.73	2.93	4.58	5.30	4.11
EV/EBIT Ratio	4.61	4.56	3.55	6.64	6.45	6.19
EV/FCF Ratio	4.76	4.68	1.59	-	-	35.01
Debt / Equity Ratio	0.16	0.16	0.35	1.12	1.03	1.33
Debt / EBITDA Ratio	0.46	0.39	0.87	2.99	1.90	2.80
Debt / FCF Ratio	0.75	0.54	0.52	-	-	23.90
Asset Turnover	1.89	2.02	1.65	1.45	2.02	1.82
Inventory Turnover	4.36	4.37	2.97	2.44	3.96	4.67
Quick Ratio	0.87	0.92	0.81	0.56	0.51	0.72
Current Ratio	1.69	1.74	1.74	1.34	1.28	1.21
Return on Equity (ROE)	17.75%	21.59%	18.96%	15.49%	40.21%	18.13%
Return on Assets (ROA)	8.07%	9.94%	7.97%	5.51%	9.47%	5.44%
Return on Capital (ROIC)	13.78%	16.61%	12.06%	8.43%	16.03%	9.00%
Return on Capital Employed (ROCE)	21.30%	26.50%	23.80%	21.60%	35.60%	23.90%
Earnings Yield	17.25%	16.00%	24.05%	23.83%	15.53%	21.76%
FCF Yield	22.38%	23.87%	92.40%	-20.23%	-7.21%	7.25%
Dividend Yield	0.03%	1.84%	3.03%	-	-	-
Payout Ratio	15.76%	13.20%	-	-	-	-
Buyback Yield / Dilution	-2.27%	-3.12%	0.56%	-0.46%	-9.05%	-
Total Shareholder Return	-2.24%	-1.29%	3.60%	-0.46%	-9.05%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.